Results 291 to 300 of about 143,588 (347)

Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors. [PDF]

open access: yesNAR Cancer
Buckley-Benbow L   +4 more
europepmc   +1 more source

BRCA1 and BRCA2 pathogenic variants increase the risk of four less common cancer types. [PDF]

open access: yesESMO Open
Sasagawa H   +15 more
europepmc   +1 more source

Comprehensive evidence for the pathogenicity of the <i>BRCA2</i> c.7847C>T (p.Ser2616Phe) variant specific to the Japanese population. [PDF]

open access: yesJ Med Genet
Yamazawa K   +33 more
europepmc   +1 more source

The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

open access: yesNature Reviews Molecular Cell Biology, 2020
The tumour suppressor breast cancer type 1 susceptibility protein (BRCA1) promotes DNA double-strand break (DSB) repair by homologous recombination and protects DNA replication forks from attrition.
Madalena Tarsounas   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Brca1 and differentiation

Mutation Research/Reviews in Mutation Research, 2002
Breast cancer is one of the most frequent malignancies affecting women. The human breast cancer gene 1 (BRCA1) gene is mutated in a distinct proportion of hereditary breast and ovarian cancers. Tumourigenesis in individuals with germline BRCA1 mutations requires somatic inactivation of the remaining wild-type allelle. Although, this evidence supports a
Marion, Kubista   +7 more
openaire   +2 more sources

Perspective on BRCA1

Breast Disease, 1998
In a very real sense, the search for a breast cancer susceptibility gene reflects the rapid evolution of molecular genetics as a field and the power of molecular technology to accelerate the pace of discovery. This search began with the study of blood proteins through biochemical analysis; the number of loci accessible was limited, and very few ...
B, Newman, E T, Liu
openaire   +2 more sources

Home - About - Disclaimer - Privacy